Management Team

  • Tracy Klein, MBA | Chief Executive Officer

    Tracy Klein has over 20 years of pharmaceutical industry sales and marketing experience, including extensive work bringing multiple small molecules and biologics to market. Ms. Klein joined Centocor while it was a medium-sized independent biotech company and helped lead Centocor to success as they grew Remicade into Johnson and Johnson’s #1 pharmaceutical product. While at Centocor, Ms. Klein spent nine years on the management team, served on the sales force structure and deployment team and several product launch teams. She is well-versed in science as well as business, holding both a B.S. in Microbiology (Pre-Med) and an MBA from Oregon State University. A native of the Northwest, she grew up outside of Oregon City, and moved to the Seattle metro area in 1990. Tracy is well-positioned to lead Inson’s strong management team through research and development and then through the commercialization of its unique drug delivery devices.

  • Douglas Swartz | Chairman, Board of Directors

    Mr. Douglas Swartz has extensive experience in the technical development, and financial and business requirements necessary for companies to succeed. Mr. Swartz has over 25 years of experience in the creation of technology start-ups. He has personally founded and lead four technology companies prior to Inson Medical Systems, Inc. These firms (Integrated Solutions, Outbound Systems, Black Labs, and Ntrapoint) represent advances in diverse fields and several have reached liquidity. His first venture, Integrated Solutions, was a company which designed and manufactured Unix servers and work- stations for corporate users. He grew that company to $6 million in sales within three years at which time it was acquired for in excess of $8 million. His second company, Outbound Systems, was formed to capitalize on opportunities in portable computing. This company raised $11 million in capital prior to being sold to Apple Computer for $4 million. In addition to his entrepreneurial ventures, Mr. Swartz has twenty-eight years of experience in technology companies, primarily in management roles. He has helped lead companies to success in all phases of product development from concept to launch. Mr. Doug Swartz earned his B.S. and M.S. Degrees in Electrical Engineering from Rensselaer Polytechnic Institute, worked towards a Ph.D. in Electrical Engineering at Stanford University (1973), and earned his M.B.A. from Northeastern University (1979).

  • Tom East | VP of Operations

    Tom East has over 25 years of pharmaceutical industry experience managing CMC (Chemistry, Manufacturing and Control), regulatory, quality and analytical programs spanning development through commercialization. Most recently, he was Senior Director, Quality Affairs at Nastech Pharmaceutical, Inc. where he led regulatory CMC and analytical groups supporting clinical and commercial products. In addition, he was the lead CMC representative during Nastech’s partnerships with Merck and Procter & Gamble. Prior to joining Nastech, Tom was with Sonus Pharmaceuticals serving as Director of Regulatory and Quality, and ProCyte Corp managing Quality Control and Analytical Services. Prior to that, he was a Research Scientist and Manager of Analytical Method Development for ALZA Corporation, in charge of commercial lot release, method development and validation. In this position, he was responsible for testing of advanced drug delivery systems used in feasibility, toxicology and clinical studies conducted in support of several regulatory filings, including Procardia XL, the most successful new product in pharmaceutical industry history at that time. He received a B.S. in Biochemistry from California State Polytechnic University, San Luis Obispo and in 2002 obtained Regulatory Affairs Certification (RAC).